This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Carbimazole and pancreatitis

Authoring team

Carbimazole: risk of acute pancreatitis

  • if acute pancreatitis occurs during treatment with carbimazole, immediately and permanently stop treatment. Re-exposure to carbimazole may result in life-threatening acute pancreatitis with a decreased time to onset

Advice for healthcare professionals:

  • cases of acute pancreatitis have been reported very infrequently during treatment with carbimazole
  • if acute pancreatitis occurs, stop carbimazole treatment immediately
  • do not use carbimazole in patients with a history of acute pancreatitis in association with previous treatment
  • re-exposure may result in life-threatening acute pancreatitis with a decreased time to onset
  • report suspected adverse drug reactions to the Yellow Card Scheme immediately

Reference:

  • MRHA (February 2019). Drug Safety Update 12(7):1-8.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page